Mitochondrial complex I: Structure, function and pathology
- 11 July 2006
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 29 (4) , 499-515
- https://doi.org/10.1007/s10545-006-0362-4
Abstract
Oxidative phosphorylation (OXPHOS) has a prominent role in energy metabolism of the cell. Being under bigenomic control, correct biogenesis and functioning of the OXPHOS system is dependent on the finely tuned interaction between the nuclear and the mitochondrial genome. This suggests that disturbances of the system can be caused by numerous genetic defects and can result in a variety of metabolic and biochemical alterations. Consequently, OXPHOS deficiencies manifest as a broad clinical spectrum. Complex I, the biggest and most complicated enzyme complex of the OXPHOS system, has been subjected to thorough investigation in recent years. Significant progress has been made in the field of structure, composition, assembly, and pathology. Important gains in the understanding of the Goliath of the OXPHOS system are: exposing the electron transfer mechanism and solving the crystal structure of the peripheral arm, characterization of almost all subunits and some of their functions, and creating models to elucidate the assembly process with concomitant identification of assembly chaperones. Unravelling the intricate mechanisms underlying the functioning of this membrane-bound enzyme complex in health and disease will pave the way for developing adequate diagnostic procedures and advanced therapeutic treatment strategies.Keywords
This publication has 132 references indexed in Scilit:
- Fulminant neurological deterioration in a neonate with Leigh syndrome due to a maternally transmitted missense mutation in the mitochondrial ND3 geneBiochemical and Biophysical Research Communications, 2005
- Mitochondrial ND5 mutations in idiopathic Parkinson’s diseaseBiochemical and Biophysical Research Communications, 2005
- CIA30 complex I assembly factor: a candidate for human complex I deficiency?Human Genetics, 2002
- The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup JHuman Genetics, 2002
- The reduction of NADH: Ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's diseaseLife Sciences, 2001
- Combined Enzymatic Complex I and III Deficiency Associated with Mutations in the Nuclear Encoded NDUFS4 GeneBiochemical and Biophysical Research Communications, 2000
- Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteinsThe EMBO Journal, 2000
- Supercomplexes in the respiratory chains of yeast and mammalian mitochondriaThe EMBO Journal, 2000
- Modular Evolution of the Respiratory NADH:Ubiquinone Oxidoreductase and the Origin of its ModulesJournal of Theoretical Biology, 1997
- NADH‐coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findingsJournal of Inherited Metabolic Disease, 1996